011504 Dapsone 8.5% / Niacinamide 4%
Product Images NDC 72934-1212

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for 011504 Dapsone 8.5% / Niacinamide 4% (NDC 72934-1212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S (2 End)

S (2 End)
The image shows a white cylindrical container labeled with usage directions for 011504 DAPSONE 8.5% / NIACINAMIDE 4%, produced by Sincerus Florida, LLC. The label includes instructions to apply topically as directed by a physician and to wash hands after use. It also provides the manufacturer's contact information and storage recommendations at controlled room temperature (20-25°C). The label indicates the product is for external, office use only and not for resale.*
FDA Label Image

2 (1212 2 Front)

2 (1212 2 Front)
Packaging label of 011504 DAPSONE 8.5% / NIACINAMIDE 4% gel in a 30gm container from Sincerus Florida, LLC. The label shows the NDC number 72934-1212-2 and states the product is a compounded drug made in the USA.*
FDA Label Image

E (1212 2 Middle)

E (1212 2 Middle)
011504 DAPSONE 8.5% / NIACINAMIDE 4% gel packaging label shows active ingredients as Dapsone USP 8.5% and Niacinamide USP 4%. Inactive ingredients include Propylene Glycol USP 5% and Suspensisse Gel 82.5%. Labeler is Sincerus Florida, LLC. The label includes Rx only and space for BUD, lot, manufacturing details, and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.